• nDatalyze terminated its proposed transaction with Prism Diversified after missing the October 31, 2026 completion deadline; no extension was agreed.
• Subscription proceeds held in escrow will be returned to subscribers; subscription receipts will be cancelled without issuing shares.
• The spin-out transaction and name change, both conditional on completion, will not proceed at this time.
• Trading in the company's common shares remains halted pending CSE review and approval of a planned reinstatement application.
• The company intends to pursue commercialization of Epitome, its main asset, whether privately or publicly.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. nDatalyze Corp. published the original content used to generate this news brief via TheNewswire (Ref. ID: 202611041650TNWSWRCACNPR_____1kEjFWw6o) on November 04, 2026, and is solely responsible for the information contained therein.